文献速递呼吸道感染呼吸危重症与机械通气

64例重型COVID-19患者的临床特征与转归分析

[Clinical characteristics and outcome of 64 patients with severe COVID-19].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2020-01-01

该回顾性研究分析了武汉肺科医院64例重型COVID-19患者,按转归分为死亡组40例与治愈组24例。死亡组肌酸激酶同工酶、肌钙蛋白、肌红蛋白、D-二聚体、乳酸脱氢酶及丙氨酸氨基转移酶均高于治愈组,心电图异常比例更高。主要死亡原因为重型肺炎并ARDS、急性心功能不全、心房纤颤及多器官功能障碍综合征。

要点

  • 重型COVID-19死亡组心肌损伤标志物及D-二聚体、LDH、ALT均高于治愈组。
  • 死亡组心电图异常比例62%,显著高于治愈组的29%。
  • 主要死亡原因为重型肺炎并ARDS及病毒性心肌炎所致急性心功能不全。

核心结论

  • 重型肺炎所致ARDS以及急性病毒性心肌炎所致急性心功能不全和心房纤颤是重型COVID-19患者的主要死亡原因。
  • 早期预防心肌损伤并积极治疗急性病毒性心肌炎可能有助于降低重型COVID-19病死率。

研究设计与样本

  • 回顾性分析2020年1月12日至2月28日武汉肺科医院收治的64例重型COVID-19患者。
  • 男36例、女28例,年龄44~85岁,中位年龄68(62,72)岁;52例(81%)合并基础疾病。
  • 按治疗转归分为死亡组40例与治愈组24例,比较一般情况、实验室检查、影像学及治疗方案。

主要发现

  • 死亡组CK-MB中位数19.0(17.0,23.0)U/L,高于治愈组16.5(13.5,19.6)U/L,P=0.014。
  • 死亡组cTnI中位数0.03(0.03,0.07)μg/L,高于治愈组0.03(0.02,0.03)μg/L,P=0.007。
  • 死亡组肌红蛋白79.5(28.7,189.0)μg/L,高于治愈组33.1(25.7,54.5)μg/L,P=0.031。
  • 死亡组D-二聚体2.0(0.6,5.2)mg/L,高于治愈组0.7(0.4,2.0)mg/L,P=0.020;LDH 465.0(337.5,606.5)U/L高于治愈组341.0(284.0,430.0)U/L,P=0.006。
  • 死亡组ALT 40.0(30.0,48.0)U/L高于治愈组32.5(24.0,40.8)U/L,P=0.047;心电图异常死亡组16例(62%)高于治愈组6例(29%),P=0.024。

关键数值与推荐

  • 死亡原因:重型肺炎并ARDS 20例,病毒性心肌炎所致急性心功能不全9例,心房纤颤3例,多器官功能障碍综合征3例,其他5例。

临床怎么用

  • 对重型COVID-19患者应监测心肌损伤标志物、D-二聚体、LDH及心电图,警惕急性病毒性心肌炎及心功能不全。
  • 早期识别并处理心肌损伤及心律失常,可能有助于改善重型COVID-19患者预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the causes of death in patients with severe COVID-19. Methods: A retrospective analysis was performed on 64 patients with severe COVID-19 admitted to Wuhan Pulmonary Hospital from January 12, 2020 to February 28, 2020. There were 36 males and 28 females, aging from 44 to 85 years[median 68 (62, 72)]. Fifty-two patients (81%) had underlying comorbidities. The patients were divided into the death group (n=40) and the survival group (n=24) according to the treatment outcomes. In the death group, 24 were male, and 16 were female, aging from 49 to 85 years [median 69 (62, 72)], with 31 cases (78%) complicated with underlying diseases. In the survival group, there were 12 males and 12 females, aging from 44 to 82 years[median 66 (61,73)], with 21 cases (88%) with comorbidities. Clinical data of the two groups were collected and compared, including general information, laboratory examinations, imaging features and treatments. For normally distributed data, independent group t test was used; otherwise, Mann Whitney test was used to compare the variables. χ(2) test and Fisher exact test was used when analyzing categorical variables. Results: The median of creatine kinase isozyme (CK-MB) in the death group was 19.0 (17.0,23.0) U/L, which was higher than that in the survival group 16.5 (13.5,19.6) U/L. The median level of cTnI in the death group was 0.03 (0.03, 0.07) μg/L, which was significantly higher than that in the survival group (0.02, 0.03) μg/L, with a statistically significant difference between the two groups (P=0.007). The concentration of myoglobin in the death group was 79.5 (28.7, 189.0) μg/L, which was higher than 33.1 (25.7, 54.5) μg/L in the survival group. The level of D-dimer in the death group was 2.0 (0.6, 5.2) mg/L, which was higher than 0.7 (0.4, 2.0) mg/L in the survival group. The LDH level of the death group was 465.0 (337.5,606.5) U/L, which was higher than that of the survibal group, 341.0 (284.0,430.0) U/L, the difference being statistically significant (P=0.006). The concentration of alanine aminotransferase in the death group was 40.0 (30.0, 48.0) U/L, which was higher than 32.5 (24.0, 40.8) U/L in the survival group, and the difference was statistically significant (P=0.047).Abnormal ECG was found in 16 cases (62%) in the death group, which was significantly higher than that in the survival group (29%), the difference being statistically significant (P=0.024) .The main causes of death were severe pneumonia with acute respiratory distress syndrome (ARDS, n=20), acute heart failure(n=9), atrial fibrillation(n=3) and multiple organ dysfunction syndrome (MODS, n=3). Conclusions: ARDS caused by severe pneumonia and acute heart failure and atrial fibrillation caused by acute viral myocarditis were the main causes of death in severe COVID-19 patients. Early prevention of myocardial injury and treatment of acute viral myocarditis complicated with disease progression may provide insights into treatment and reduction of mortality in patients with severe COVID-19. 目的: 探讨重症新型冠状病毒肺炎(COVID-19)患者的临床特征及转归。 方法: 回顾性分析2020年1月12日至2月28日武汉肺科医院收治的64例重症COVID-19患者,男36例,女28例,年龄44~85岁,中位年龄为68(62,72)岁;52例(81%)合并基础疾病。按治疗转归分为死亡组40例,男24例,女16例,年龄49~85岁,中位年龄69 (62,72)岁;合并基础疾病31例(78%)。治愈组24例,男12例,女12例,年龄44~82岁,中位年龄66(61,73)岁;合并基础疾病21例(88%)。收集两组患者的临床资料,包括一般情况、实验室检查、影像学检查、治疗方案等,正态分布的计量资料采用独立样本t检验;非正态分布的计量资料采用Mann-Whitney U检验;计数资料采用卡方检验或Fisher精确检验。 结果: 入院第一天,死亡组患者肌酸激酶同工酶水平中位数为19.0(17.0,23.0) U/L,高于治愈组的16.5(13.5,19.6) U/L,两组比较差异有统计学意义(P=0.014)。死亡组肌钙蛋白水平中位数为0.03(0.03,0.07) μg/L,显著高于治愈组的0.03(0.02,0.03) μg/L,两组比较差异有统计学意义(P=0.007)。死亡组肌红蛋白浓度为79.5(28.7,189.0) μg/L,高于治愈组的33.1(25.7,54.5) μg/L,差异有统计学意义(P=0.031)。死亡组D-二聚体水平为2.0(0.6,5.2) mg/L,高于治愈组的0.7(0.4,2.0) mg/L,差异有统计学意义(P=0.020)。死亡组乳酸脱氢酶水平为465.0(337.5,606.5) U/L,高于治愈组的341.0(284.0,430.0) U/L,差异有统计学意义(P=0.006)。死亡组丙氨酸氨基转移酶浓度为40.0(30.0,48.0) U/L,高于治愈组的32.5(24.0,40.8) U/L,差异有统计学意义(P=0.047)。47例行心电图检查的患者中,22例(47%)心电图异常,其中死亡组心电图异常16例(62%),治愈组6例(29%),两组比较差异有统计学意义(P=0.024)。死亡原因:重症肺炎并急性呼吸窘迫综合征(ARDS)20例,病毒性心肌炎导致的急性心功能不全9例,心房纤颤3例,多器官功能障碍综合征3例,其他5例。 结论: 病毒性心肌炎导致的急性心功能不全是导致重症COVID-19患者死亡的原因。早期预防心肌损伤,积极治疗疾病进展过程中并发的急性病毒性心肌炎,可能降低重症COVID-19患者的病死率。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhu Q, Zhang W, Wang Q, et al. [Clinical characteristics and outcome of 64 patients with severe COVID-19]. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 32727177. doi:10.3760/cma.j.cn112147-20200308-00275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。